Abnormal Brain-Derived Neurotrophic Factor Exon IX Promoter Methylation, Protein, and mRNA Levels in Patients with Major Depressive Disorder
Year: 2019
Type: article
Study design: Observational Study
Abstract: Brain-derived neurotrophic factor (BDNF) exon IX promoter methylation levels, serum BDNF protein levels, and serum mRNA levels were investigated in patients with major depressive disorder (MDD) and healthy controls. Over two years, 51 patients with MDD and 62 healthy controls were recruited. Peripheral blood was drawn from all participants to analyze the BDNF exon IX promoter methylation levels as well as serum BDNF protein and mRNA levels, at baseline and after four weeks of antidepressant treatment. Methylation sequential analysis showed that patients with MDD (n = 39) had a higher methylation level at CpG site 217 and lower methylation levels at CpG site 327 and CpG site 362. Drug responders (n = 25) had a higher methylation level at CpG site 24 and CpG site 324 than the non-responders (n = 11). Patients with MDD had a lower serum BDNF protein and mRNA levels than the healthy controls. In conclusion, these results showed that BDNF exon IX promoter methylation levels, serum BDNF protein level, and serum BDNF mRNA level could contribute to the pathophysiology of a major depressive disorder.
Source: Journal of Clinical Medicine
DOI: 10.3390/jcm8050568
Authors: Men-Ting Hsieh(Data curation, Investigation, Methodology, Software, Writing – original draft), Chin-Chuen Lin(Data curation, Formal analysis, Investigation, Methodology, Software, Writing – original draft), Chien-Te Lee(Data curation, Investigation, Methodology, Resources, Validation, Writing – review & editing), Tiao-Lai Huang(Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Writing – review & editing)
Institutions: Chang Gung University, Kaohsiung Chang Gung Memorial Hospital
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,824
Funder: National Science Council
Award: G8575815517
OpenAlex ID: W2940619505
